Home » Topics » BioWorld Science

BioWorld Science
RSS

LeukoSite and Oxford Asymmetry collaboration in IBD

Oct. 4, 1996

Promising phase III results with treatment for ulcerative colitis

Oct. 4, 1996

Clinical trial on oral H. pylori vaccine completed

Oct. 4, 1996

Grant to fund phase III trial of Synsorb Pk

Oct. 4, 1996

FDA approves IVAX drug for IC

Oct. 4, 1996

Glaxo Wellcome reports new diuretics

Oct. 4, 1996

BB-10153 development progresses

Oct. 4, 1996

Fibrinogen antagonists reported by Searle

Oct. 4, 1996

Boehringer Mannheim reports fibrinogen antagonists for thromboembolic conditions

Oct. 4, 1996

Joint venture formed for development of oral heparin

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...